Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 3:56 AM
Ignite Modification Date: 2025-12-25 @ 3:56 AM
NCT ID: NCT05075902
Eligibility Criteria: Inclusion Criteria: * Postmenopausal women (amenorrhea of at least 12 months; Estradiol \<32.2 pg / mL), * Aged between 50 and 70 years, * Able to do aerobic exercise on track, do not have physical problems or cardiovascular complications that prevent them from exercising. * Non-smokers , * Who do not use Hormone Therapy or have not finished the treatment for more than 1 year, * As diagnostic criteria for cardiometabolic diseases: Obesity (BMI\> 29.9 kg / m2; Use of antihypertensive drugs and/or hypertension (systolic blood pressure at rest \> 139 mmHg and diastolic blood pressure \> 89 mmHg; dyslipidemia (LDL ≥160mg / dL and / or triglycerides ≥150mg / dL and / or total cholesterol ≥190mg / dL and / or HDL ≤50mg / dL. In the case of diabetics (blood glucose \> 126 mg / dL and / or HbA1c ≥ 6.5% and diagnosed with type 2 diabetes mellitus: for at least one year, being using a hypoglycemic and clinically stable for up to minimum 6 months, with glycemic control by medication or exogenous insulin and without chronic complications such as diabetic foot, nephropathy, retinopathy or neuropathies. Exclusion Criteria: * Present some inability to carry out the prescribed training volume or intensity, * Not obtain medical clearance after maximum exercise test * Start practicing another physical exercise protocol concurrently with this project.
Healthy Volunteers: True
Sex: FEMALE
Minimum Age: 50 Years
Maximum Age: 70 Years
Study: NCT05075902
Study Brief:
Protocol Section: NCT05075902